Literature DB >> 22423153

Multidrug-resistant tuberculosis today.

A Matteelli, R Centis, L D'Ambrosio, G B Migliori.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22423153      PMCID： PMC3302557          DOI： 10.2471/BLT.11.097360

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


× No keyword cloud information.
  5 in total

1.  The global rise of extensively drug-resistant tuberculosis: is the time to bring back sanatoria now overdue?

Authors:  Keertan Dheda; Giovanni B Migliori
Journal:  Lancet       Date:  2011-10-25       Impact factor: 79.321

2.  Tuberculosis and HIV co-infection: do we have a surveillance system in Europe?

Authors:  E Pontali; M B Pasticci; A Matteelli; F Baldelli; G B Migliori
Journal:  Eur Respir J       Date:  2011-12       Impact factor: 16.671

3.  TB and M/XDR-TB infection control in European TB reference centres: the Achilles' heel?

Authors:  G Sotgiu; L D'Ambrosio; R Centis; G Bothamley; D M Cirillo; S De Lorenzo; G Guenther; K Kliiman; R Muetterlein; V Spinu; M Villar; J P Zellweger; A Sandgren; E Huitric; C Lange; D Manissero; G B Migliori
Journal:  Eur Respir J       Date:  2011-11       Impact factor: 16.671

4.  Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010.

Authors:  Matteo Zignol; Wayne van Gemert; Dennis Falzon; Charalambos Sismanidis; Philippe Glaziou; Katherine Floyd; Mario Raviglione
Journal:  Bull World Health Organ       Date:  2011-11-07       Impact factor: 9.408

5.  Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk.

Authors:  Alena Skrahina; Henadz Hurevich; Aksana Zalutskaya; Evgeni Sahalchyk; Andrei Astrauko; Wayne van Gemert; Sven Hoffner; Valiantsin Rusovich; Matteo Zignol
Journal:  Eur Respir J       Date:  2011-10-17       Impact factor: 16.671
  5 in total
  5 in total

1.  A new free-cost e-service supporting clinicians to manage their difficult-to-treat TB cases: the ERS-WHO TB consilium.

Authors:  Lia D'Ambrosio; Marina Tadolini; Rosella Centis; Giovanni Battista Migliori
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

2.  De Novo Emergence of Genetically Resistant Mutants of Mycobacterium tuberculosis from the Persistence Phase Cells Formed against Antituberculosis Drugs In Vitro.

Authors:  Jees Sebastian; Sharmada Swaminath; Rashmi Ravindran Nair; Kishor Jakkala; Atul Pradhan; Parthasarathi Ajitkumar
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

Review 3.  Rapid Molecular Assays for the Diagnosis of Drug-Resistant Tuberculosis.

Authors:  Louansha Nandlal; Rubeshan Perumal; Kogieleum Naidoo
Journal:  Infect Drug Resist       Date:  2022-08-29       Impact factor: 4.177

Review 4.  Emergence in Western African countries of MDR-TB, focus on Côte d'Ivoire.

Authors:  Euloge Ekaza; Raymond Kouassi N'Guessan; Adèle Kacou-N'Douba; N'Guetta Aka; Jacquemin Kouakou; Françoise Le Vacon; Fréderic Altare; Gilles Potel; Marie-France de-La-Cochetiere
Journal:  Biomed Res Int       Date:  2013-09-04       Impact factor: 3.411

5.  Multidrug-Resistant TB: Implementing the Right to Health through the Right to Enjoy the Benefits of Scientific Progress.

Authors:  Leslie London; Helen Cox; Fons Coomans
Journal:  Health Hum Rights       Date:  2016-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.